JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for SUPERNUS PHARMACEUTICALS INC · Experience in developing and commercializing products that treat central nervous system

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

issues related to the pharmaceutical industry

Medicare/Medicaid

issues related to Medicare drug reimbursement

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.